Pipeline

    Pipeline

      • Oncology Oncology

        Our oncology pipeline is grounded in a deep understanding of tumor biology and drug resistance mechanisms, combined with a sustained pursuit of​ innovative drug design strategies.

      • Infectious diseases Infectious diseases

        Our infectious disease pipeline is dedicated to developing broad-spectrum, small-molecule antiviral drugs. Target indications include epidemic diseases such as coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS).

      在研管线列表
      Drug Candidate
      Therapeutic Area
      Target
      Drug Discovery
      Drug Optimization
      Preclinical
      Phase I
      Phase II
      Phase III
      Approved
      Infectious Diseases
      3CLpro
      Infectious Diseases
      3CLpro
      Infectious Diseases
      RdRp
      Oncology
      Epigenetics and Transcription Factors
      Oncology
      Epigenetics and Transcription Factors
      Oncology
      Epigenetics and Transcription Factors
      Oncology
      MAPK Pathway
      Oncology
      MAPK Pathway
      Oncology
      MAPK Pathway
      Oncology
      MAPK Pathway
      Oncology
      MAPK Pathway
      Oncology
      MAPK Pathway